TABLE 2.
Demographics and clinical characteristics of aspirin‐sensitive versus aspirin‐nonsensitive patients
| Characteristics | Aspirin sensitive (n = 114) | Aspirin nonsensitive (n = 36) |
|---|---|---|
| Mean (SD) | ||
| Age, y, mean (SD) | 68 (13) | 69 (9) |
| Platelet count, 103/μL | 218 (64) | 234 (81) |
| Leukocyte count, 103/μL | 7.4 (2) | 7.9 (2) |
| Hematocrit | 39.4 (5) | 38.7 (5) |
| Frequency (%) | ||
| Sex, male | 70 (61) | 27 (75) |
| Hypertension | 82 (72) | 35 (97) |
| Hypercholesterolemia | 89 (78) | 32 (89) |
| Diabetes | 41 (36) | 17 (47) |
| Smoking history | 86 (75) | 29 (81) |
| Statin | 83 (72) | 28 (78) |
| ACEi/ARB | 62 (54) | 18 (50) |
| Beta blocker | 31 (27) | 11 (31) |
| Calcium channel blocker | 25 (23) | 7 (19) |
Continuous variables are showing by mean (standard deviation), and categorical variables are shown in number (percent). No significant difference between aspirin‐sensitive and aspirin‐nonsensitive patients in any of the characteristics with P >.05. Differences between groups were compared using chi‐square test for categorical variables, and Mann‐Whitney test for continuous variables.
Abbreviations: ACEi, angiotensin‐converting enzyme (ACE) inhibitor; ARB, angiotensin receptor blocker.